INDIANAPOLIS, May 2, 2016 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today released its first-ever integrated report, combining two of the company's traditional documents: its annual report and its corporate responsibility report. Lilly's 2015 Integrated Report covers the company's business and financial results along with progress on its broad-based social, employment, and environmental activities. The new approach advances Lilly's efforts to continually improve its corporate reporting and better reflect the company's total impact on society.
In a video message to stakeholders, Lilly Chairman, President and CEO John Lechleiter, Ph.D., said: "In 2015, we turned the corner in our business results and began to grow again after a prolonged period of patent expirations. At the same time, we made a great deal of progress in advancing our pipeline of potential new medicines and demonstrated our ongoing commitment to corporate responsibility. We continue to better align our philanthropic goals with our fundamental business strategies and, as a result, we're having greater impact."
Integrated Report Highlights
In 2015, despite unprecedented currency headwinds brought on by the strengthening U.S. dollar, Lilly returned to revenue growth, led by sales of existing products and several new product launches, and significant contributions from the company's enlarged Elanco animal health business.
Lilly achieved significant advances in its pipeline of molecules in clinical development in 2015. As of early 2016, the company had nine molecules in Phase III testing or regulatory review, including potential medicines that hold the promise of advances in the treatment of immunological disorders, Alzheimer's disease, and various pain conditions.
On the corporate responsibility front, the company continued to progress its global health work through the Lilly NCD Partnership and the Lilly MDR-TB Partnership, which are focused on the growing challenges of non-communicable diseases, such as diabetes, and multidrug-resistant tuberculosis. Elanco continued to address the key link between nutrition and health through its partnership with Heifer International and through HATCH™ for Hunger, a community partnership to provide eggs to undernourished people in the Midwest region of the U.S.
Throughout 2015, Lilly employees extended the company's legacy of volunteering and giving to strengthen communities around the world. In the first five years of Lilly's Connecting Hearts Abroad program, nearly 1,000 employees have worked a combined 64,000 hours during two-week assignments in impoverished communities across Africa, Asia, Eastern Europe, and Latin America. Additionally, Lilly employees worldwide have volunteered 825,000 hours since 2008 through the company's annual Global Day of Service. And in 2015, Lilly and United Way advanced their nearly 100-year relationship through a new approach that paired 50 Lilly teams with United Way agency partners with the goal of helping the agencies advance their missions and serve more people.
About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and newsroom.lilly.com/social-channels. C-LLY
Refer to: David Marbaugh; email@example.com; 317-489-7109
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lilly-releases-first-ever-integrated-report-300261040.html
SOURCE Eli Lilly and Company